L.P. ACORN BIOVENTURES - 25 Jun 2025 SCHEDULE 13G Report for Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL)

Filing Manager
L.P. ACORN BIOVENTURES
Reporting Manager
Anders Hove
Security
Candel Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
CADL
Shares outstanding
49,625,327 shares
Disclosed Ownership
2,580,517 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
30 Jun 2025, 09:55:23 UTC
Date of event
25 Jun 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 1,083,818 0 1,083,818 Anders Hove Manager of General Partner
ACORN BIOVENTURES 2, L.P. 3% 1,496,699 0 1,496,699 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 1,083,818 0 1,083,818 Anders Hove Manager
Acorn Capital Advisors GP2, LLC 3% 1,496,699 0 1,496,699 Anders Hove Manager
Anders Hove 5.2% 2,580,517 0 2,580,517 Anders Hove Individually